| dc.contributor.author | Harvey, J | en_US |
| dc.contributor.author | Stuart, B | en_US |
| dc.contributor.author | Williams, HC | en_US |
| dc.date.accessioned | 2024-03-14T10:06:45Z | |
| dc.date.available | 2024-01-25 | en_US |
| dc.date.issued | 2024 | en_US |
| dc.identifier.issn | 1663-9812 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/95328 | |
| dc.format.extent | 1372259 - ? | en_US |
| dc.language | eng | en_US |
| dc.relation.ispartof | Front Pharmacol | en_US |
| dc.rights | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. | |
| dc.subject | atopic dermatitis | en_US |
| dc.subject | commentary | en_US |
| dc.subject | hydrocortisone | en_US |
| dc.subject | randomized controlled trial | en_US |
| dc.subject | tacrolimus | en_US |
| dc.title | Commentary: A comparative randomized clinical trial evaluating the efficacy and safety of tacrolimus versus hydrocortisone as a topical treatment of atopic dermatitis in children. | en_US |
| dc.type | Article | |
| dc.rights.holder | © 2024 Harvey, Stuart and Williams. | |
| dc.identifier.doi | 10.3389/fphar.2024.1372259 | en_US |
| pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/38487167 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published online | en_US |
| pubs.volume | 15 | en_US |
| dcterms.dateAccepted | 2024-01-25 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
